Flexner Dean's Lecture - David G. Nathan, M.D.
"Clincial Research: An Uphill Climb"
David G. Nathan, MD, is an acclaimed pediatric hematologist who served as the President of the Dana-Farber Cancer Institute from 1995-2000. He has received numerous awards for his outstanding teaching, cutting-edge research, and excellence in clinical care delivery. Dr. Nathan's career has had a remarkably foundational influence on the understanding of disorders affecting red cells and granulocytes, particularly thalassemia. In 2011, Dr. Nathan was presented with the Wallace H. Coulter Award for Lifetime Achievement in Hematology, the American Society of Hematology's highest honor.
Dr. Nathan graduated from Harvard College in 1951 and Harvard Medical School in 1955, and continued on within the Harvard Health System as an intern, resident, and hematologist at the Brigham and Women's Hospital. From 1959-1966, Dr. Nathan became the Chief of the Division of Hematology and Oncology at the Children's Hospital Boston and Dana-Farber Cancer Institute. Dr. Nathan's numerous scientific advances include his team's development of the first prenatal diagnostic test for thalassemia and sickle cell anemia and the introduction of hydroxyurea (HU) for the improvement of sickle cell anemia. He further collaborated with his trainees to develop the first successful treatment for iron overload (subcutaneous deferoxamine) for thalassemia patients undergoing chronic transfusion therapy.
Dr. Nathan, a Robert A. Stranahan Distinguished Professor of Pediatrics and a Professor of Medicine at Harvard Medical School, has also trained, supported and mentored more than 100 of the world's leading hematologists.